Kenneth K. Chan

12.2k citations

172 papers · 8.1k indexed · 1 hit paper · h-index 47

Impact in

Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Hematology top 1%
- Acute Myeloid Leukemia Research

Papers in

Hematology 24
- Acute Myeloid Leukemia Research 21
Toxicology 5

Co-authors: Zhongfa Liu Guido Marcucci Shujun Liu Michael R. Grever Ramiro Garzon Zhiliang Xie Carlo M. Croce John M. Cassady
Journals: Blood (16 papers)Cancer Chemotherapy and Pharmacology (12 papers)Clinical Cancer Research (7 papers)The AAPS Journal (7 papers)Journal of Pharmaceutical and Biomedical Analysis (6 papers)
Partner nations: United States Canada China

In The Last Decade

Kenneth K. Chan

171 papers receiving 7.9k citations

Hit Papers

align trajectories log scale

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B 2007 · 1.3k citations

Peers

Countries citing papers authored by Kenneth K. Chan

Since Specialization

Citations

This map shows the geographic impact of Kenneth K. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth K. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth K. Chan more than expected).

Fields of papers citing papers by Kenneth K. Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth K. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth K. Chan. The network helps show where Kenneth K. Chan may publish in the future.

Co-authors

The 25 scholars most cited alongside Kenneth K. Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kenneth K. Chan Line = papers co-authored together Kenneth K. Chan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	T Cell Phenotype and T Cell Receptor Repertoire in Patients with Major Depressive Disorder Frontiers in Immunology ·Kostas Patas, Anne Willing, Cüneyt Demiralay, Jan Broder Engler, Andreea‐Roxana Lupu, Caren Ramien, Tobias Schäfer, Christian Gach, Laura Stumm, Kenneth K. Chan, Marissa Vignali, Petra Arck, Manuel A. Friese, Ole Pleß, Klaus Wiedemann, Agorastos Agorastos, Stefan M. Gold	2018	56
2	Preclinical Pharmacokinetics Study of R- and S-Enantiomers of the Histone Deacetylase Inhibitor, AR-42 (NSC 731438), in Rodents The AAPS Journal ·Hao Cheng, Zhiliang Xie, W.P. Jones, Xiaohui Wei, Zhongfa Liu, Dasheng Wang, Samuel K. Kulp, Jiang Wang, Christopher C. Coss, Ching‐Shih Chen, Guido Marcucci, Ramiro Garzon, Joseph M. Covey, Mitch A. Phelps, Kenneth K. Chan	2016	12
3	Subchronic Oral Toxicity Study of Decitabine in Combination With Tetrahydrouridine in CD-1 Mice International Journal of Toxicology ·Pramod Terse, Kory J. Engelke, Kenneth K. Chan, Yonghua Ling, Douglas Sharpnack, Yogen Saunthararajah, Joseph M. Covey	2014	10
4	Targeted Delivery of microRNA-29b by Transferrin-Conjugated Anionic Lipopolyplex Nanoparticles: A Novel Therapeutic Strategy in Acute Myeloid Leukemia Clinical Cancer Research ·Xiaomeng Huang, Sebastian Schwind, Bo Yu, Ramasamy Santhanam, Hongyan Wang, Pia Hoellerbauer, Alice S. Mims, Rebecca B. Klisovic, Alison R. Walker, Kenneth K. Chan, William Blum, Danilo Perrotti, John C. Byrd, Clara D. Bloomfield, Michael A. Caligiuri, Robert J. Lee, Ramiro Garzon, Natarajan Muthusamy, Ly James Lee, Guido Marcucci	2013	151
5	Increased CDA Expression/Activity in Males Contributes to Decreased Cytidine Analog Half-Life and Likely Contributes to Worse Outcomes with 5-Azacytidine or Decitabine Therapy Clinical Cancer Research ·Reda Z. Mahfouz, Ania Jankowska, Quteba Ebrahem, Xiaorong Gu, Valeria Visconte, Ali Tabarroki, Pramod Terse, Joseph M. Covey, Kenneth K. Chan, Yonghua Ling, Kory J. Engelke, Mikkael A. Sekeres, Ramón V. Tiu, Jaroslaw P. Maciejewski, Tomas Radivoyevitch, Yogen Saunthararajah	2013	105
6	Effects of Human Oral Mucosal Tissue, Saliva, and Oral Microflora on Intraoral Metabolism and Bioactivation of Black Raspberry Anthocyanins Cancer Prevention Research ·Susan R. Mallery, Deric E. Budendorf, Matthew P. Larsen, Ping Pei, Meng Tong, Andrew S. Holpuch, Peter E. Larsen, Gary D. Stoner, Henry W. Fields, Kenneth K. Chan, Yonghua Ling, Zhongfa Liu	2011	90
7	CCI-779 Inhibits Cell-Cycle G2–M Progression and Invasion of Castration-Resistant Prostate Cancer via Attenuation of UBE2C Transcription and mRNA Stability Cancer Research ·Hongyan Wang, Chunpeng Zhang, Anna Rorick, Dayong Wu, Ming Chiu, Jennifer M. Thomas‐Ahner, Zhong Chen, Hongyan Chen, Steven K. Clinton, Kenneth K. Chan, Qianben Wang	2011	47
8	Resistance to the Translation Initiation Inhibitor Silvestrol is Mediated by ABCB1/P-Glycoprotein Overexpression in Acute Lymphoblastic Leukemia Cells The AAPS Journal ·Sneha Gupta, Ellen J. Sass, Melanie E. Davis, Ryan B. Edwards, Gerard Lozanski, Nyla A. Heerema, Amy Lehman, Xiaoli Zhang, David Jarjoura, John C. Byrd, Li Pan, Kenneth K. Chan, A. Douglas Kinghorn, Mitch A. Phelps, Michael R. Grever, David Lucas	2011	63
9	Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice Cancer Chemotherapy and Pharmacology ·Zhongfa Liu, Ming Chiu, Jiang Wang, Wei Chen, Winston Yen, Patty Fan‐Havard, Xuhui Lee, Kenneth K. Chan	2011	139
10	A liquid chromatography/atmospheric pressure ionization tandem mass spectrometry quantitation method for nevirapine and its two oxidative metabolites, 2‐hydroxynevirapine and nevirapine 4‐carboxylic acid, and pharmacokinetics in baboons Rapid Communications in Mass Spectrometry ·Zhongfa Liu, Patty Fan‐Havard, Zhiliang Xie, Chen Ren, Kenneth K. Chan	2007	9
11	Preclinical pharmacokinetic studies with s-HDAC-42 (NSC 736012), an inhibitor of histone deacetylase, by LC-MS/MS Cancer Research ·Hao Cheng, Zhongfa Liu, Samuel K. Kulp, Ching‐Shih Chen, Joseph M. Covey, Kenneth K. Chan	2006	2
12	Quantification of valproic acid and its metabolite 2-propyl-4-pentenoic acid in human plasma using HPLC-MS/MS Journal of Chromatography B ·Hao Cheng, Zhongfa Liu, William Blum, John C. Byrd, Rebecca B. Klisovic, Michael R. Grever, Guido Marcucci, Kenneth K. Chan	2006	42
13	Analytical method development and pharmacokinetics studies with parthenolide (NSC 157035) and a water-soluble analog (NSC 734325) Cancer Research ·Deping Cheng, Jim Xiao, Hao Cheng, Zhongfa Liu, Joseph M. Covey, Kenneth K. Chan	2005	2
14	Hormonal Effect on Psoriasis in Pregnancy and Post Partum Archives of Dermatology ·Jenny E. Murase, Kenneth K. Chan, Thomas J. Garite, Dan M. Cooper, Gerald D. Weinstein	2005	144
15	DNA Sequence Specificity for Topoisomerase II Poisoning by the Quinoxaline Anticancer Drugs XK469 and CQS Molecular Pharmacology ·Hanlin Gao, Edith F. Yamasaki, Kenneth K. Chan, Linus L. Shen, Robert M. Snapka	2003	38
16	Identification of thiols and glutathione conjugates of depsipeptide FK228 (FR901228), a novel histone protein deacetylase inhibitor, in the blood Rapid Communications in Mass Spectrometry ·Jim Xiao, John C. Byrd, Guido Marcucci, Michael R. Grever, Kenneth K. Chan	2003	32
17	Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patients Cancer Chemotherapy and Pharmacology ·Jing Liu, Eric H. Kraut, Jonathan Bender, Rebecca Brooks, Stanley P. Balcerzak, Michael R. Grever, Harriet Stanley, Steven M. D’Ambrosio, Ruth E. Gibson‐D'Ambrosio, Kenneth K. Chan	2002	23
18	Electrospray LC–MS/MS quantitation, stability, and preliminary pharmacokinetics of bradykinin antagonist polypeptide B201 (NSC 710295) in the mouse Journal of Pharmaceutical and Biomedical Analysis ·Wan Yong Feng, Kenneth K. Chan, Joseph M. Covey	2002	22
19	N-acetyltransferase 2 phenotype but not NAT110 genotype affects aminobiphenyl-hemoglobin adduct levels. PubMed* ·Nicole Probst‐Hensch, Douglas A. Bell, Mary Ann Watson, Paul L. Skipper, Steven R. Tannenbaum, Kenneth K. Chan, Ronald K. Ross, Mimi C. Yu	2000	39
20	Phase I and pharmacologic evaluation of intraperitoneal 5-fluoro-2′-deoxyuridine Cancer Chemotherapy and Pharmacology ·Franco M. Muggia, Kenneth K. Chan, Christy Russell, Nicoletta Colombo, James L. Speyer, Kishore Sehgal, Susan Jeffers, Joan Sorich, Lawrence Leichman, Uziel Beller, E.Mark Beckman	1991	20

About Kenneth K. Chan

Kenneth K. Chan is a scholar working on Hematology, Toxicology, Molecular Biology, Cancer Research and Oncology, having authored 172 papers that have together received 8.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (21 papers), Epigenetics and DNA Methylation (20 papers), Histone Deacetylase Inhibitors Research (17 papers), Acute Lymphoblastic Leukemia research (16 papers), Cancer therapeutics and mechanisms (13 papers), Chemotherapy-induced organ toxicity mitigation (13 papers), Cancer Treatment and Pharmacology (11 papers) and Advanced biosensing and bioanalysis techniques (10 papers). The work is most often cited by research in Cancer Research (1.5k citations), Hematology (930 citations), Molecular Biology (5.0k citations), Molecular Medicine (337 citations) and Oncology (1.3k citations). Kenneth K. Chan has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Zhongfa Liu, Guido Marcucci, Shujun Liu, Michael R. Grever, Ramiro Garzon, Zhiliang Xie, Carlo M. Croce, John M. Cassady, Heinz G. Floss and George A. Calin. Their work appears in journals such as Blood, Cancer Chemotherapy and Pharmacology, Clinical Cancer Research, The AAPS Journal and Journal of Pharmaceutical and Biomedical Analysis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact